ACTG1 Gene Deafness Autosomal Dominant Type 20 Genetic Test
At DNA Labs UAE, we offer the ACTG1 Gene Deafness Autosomal Dominant Type 20 Genetic Test. This test helps diagnose individuals with autosomal dominant type 20 deafness, which is associated with the ACTG1 gene.
Test Components
- Price: 4400.0 AED
Sample Condition
We require a blood sample for this test.
Report Delivery
The test results will be delivered within 3 to 4 weeks.
Method
We use NGS (Next-Generation Sequencing) technology for this genetic test.
Test Type
This test is specifically designed for Ear Nose Throat Disorders.
Doctor
This test is conducted by an ENT Doctor.
Test Department
This test falls under the Genetics department.
Pre Test Information
Before undergoing the EYA1 Gene Branchiootic Syndrome Type 1 NGS Genetic DNA Test, we recommend a Genetic Counselling session to gather the clinical history of the patient. This session will also help draw a pedigree chart of family members affected by the EYA1 Gene Branchiootic Syndrome Type 1 NGS Genetic DNA Test gene EYA3.
Test Details
The ACTG1 gene is associated with a type of deafness known as autosomal dominant type 20. This means that a person only needs to inherit one copy of the mutated gene from one parent to develop the condition. Our NGS genetic test can analyze multiple genes simultaneously, including the ACTG1 gene, to identify any mutations or variations that may be causing the condition.
To perform this test, we will obtain a DNA sample, usually through a blood sample or cheek swab, and then sequence the DNA to identify any genetic changes in the ACTG1 gene. This information can help diagnose individuals with autosomal dominant type 20 deafness and provide insights into the specific genetic variant causing the condition.
NGS genetic testing is particularly beneficial for individuals and families with a history of deafness or suspected genetic conditions. It can aid in accurate diagnosis, provide information about the inheritance pattern, and assist in genetic counseling and family planning decisions.
Test Name | ACTG1 Gene Deafness autosomal dominant type 20 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA3 |
Test Details |
The ACTG1 gene is associated with a type of deafness known as autosomal dominant type 20. Autosomal dominant means that a person only needs to inherit one copy of the mutated gene from one parent to develop the condition. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously. In the case of ACTG1 gene deafness, an NGS genetic test can identify any mutations or variations in the ACTG1 gene that may be causing the condition. The test involves obtaining a DNA sample, usually through a blood sample or cheek swab, and then sequencing the DNA to identify any genetic changes in the ACTG1 gene. This can help diagnose individuals with autosomal dominant type 20 deafness and provide information about the specific genetic variant causing the condition. NGS genetic testing can be beneficial for individuals and families with a history of deafness or suspected genetic conditions. It can help with accurate diagnosis, provide information about the inheritance pattern, and assist in genetic counseling and family planning decisions. |